Massimo Tombesi
Overview
Explore the profile of Massimo Tombesi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
221
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Avanzini F, Marzona I, Baviera M, Barlera S, Milani V, Caimi V, et al.
Eur J Prev Cardiol
. 2015 Nov;
23(9):947-55.
PMID: 26525065
Background: Although high cardiovascular risk patients should be the main target of preventive strategies, modifiable risk factors are often inadequately controlled. Aim: To assess feasibility and results of a comprehensive...
2.
Roncaglioni M, Tombesi M, Silletta M
N Engl J Med
. 2013 Aug;
369(8):781-2.
PMID: 23964942
No abstract available.
3.
Roncaglioni M, Tombesi M, Avanzini F, Barlera S, Caimi V, Longoni P, et al.
N Engl J Med
. 2013 May;
368(19):1800-8.
PMID: 23656645
Background: Trials have shown a beneficial effect of n-3 polyunsaturated fatty acids in patients with a previous myocardial infarction or heart failure. We evaluated the potential benefit of such therapy...
4.
Tognoni G, Caimi V, Tombesi M, Visentin G
Prim Health Care Res Dev
. 2012 Jan;
13(1):1-9.
PMID: 22222016
Aims And Background: The critical importance of a closer and structural involvement of primary care in research has been increasingly recognized over the last several years, and has been the...
5.
Roccatagliata D, Avanzini F, Monesi L, Caimi V, Lauri D, Longoni P, et al.
Vasc Health Risk Manag
. 2007 Feb;
2(4):507-14.
PMID: 17323606
Objectives: To assess the pharmacological treatment and the control of major modifiable cardiovascular risk factors in everyday practice according to the patients' cardiovascular risk level. Methods: In a cross-sectional study...
6.
Bianchi G, Bracarda S, Bruzi P, Bufo P, Celesti R, De Maria M, et al.
Arch Ital Urol Androl
. 2006 Jan;
77(3 Suppl 1):63-5.
PMID: 16402733
No abstract available.
7.
Monesi L, Avanzini F, Barlera S, Caimi V, Lauri D, Longoni P, et al.
Eur J Clin Pharmacol
. 2005 Jul;
61(8):595-601.
PMID: 16021439
Objective: To evaluate the appropriate prescription of antiplatelets according to patients' global cardiovascular risk level in everyday practice. Methods: In a cross-sectional study, general practitioners (GPs) identified a random sample...
8.
Roncaglioni M, Avanzini F, Roccatagliata D, Monesi L, Tamayo-Benitez D, Tombesi M, et al.
Eur J Cardiovasc Prev Rehabil
. 2004 Jun;
11(3):233-8.
PMID: 15179106
Background: Although risk assessment charts have been proposed to identify patients at high cardiovascular risk, in everyday practice general practitioners (GPs) often use their knowledge of the patients to estimate...